Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients.

Stefania Stella Silvia Rita Vitale Fabio Stagno Michele MassiminoAdriana PumaCristina TomarchioMaria Stella PennisiElena Tirrò Chiara RomanoFrancesco Di RaimondoEmma CacciolaRossella CacciolaLivia Manzella

Published in: Diagnostics (Basel, Switzerland) (2022)

This automatic method can replace the more laborious manual workflow, especially when high-throughput isolations from blood of CML patients are needed.

Keyphrases

end stage renal disease
high throughput
ejection fraction
chronic kidney disease
newly diagnosed
chronic myeloid leukemia
prognostic factors
stem cells
deep learning
bone marrow
neural network